Miller Howard Investments’s Medifast MED Stock Holding History

Miller Howard Investments’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-3,023	Closed	-$313K	–	200
2023 Q1	$313K	Buy	3,023 +36	+1%	+$3.99K	0.01%	170
2022 Q4	$345K	Buy	+2,987	New	+$348K	0.01%	170
2022 Q3	–	Sell	-1,626	Closed	-$294K	–	200
2022 Q2	$294K	Buy	+1,626	New	+$291K	0.01%	176

Other funds holding MED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Miller Howard Investments's MED Position: Q2 2023 in Review

Miller Howard Investments sold out of Medifast (MED) in Q2 2023, closing a stake of 3,023 shares — an estimated $313K sold.

Miller Howard Investments first reported a position in MED in Q2 2022 and held it in 3 quarters. The position peaked at $345K in Q4 2022. 236 funds tracked by Wall St. Rank hold MED as of Q2 2023.

Miller Howard Investments reported no remaining Medifast position as of Q2 2023 after selling out during the quarter.
Miller Howard Investments sold 3,023 Medifast shares in Q2 2023, an estimated $313K.
Miller Howard Investments first reported a position in Medifast in Q2 2022 and held it in 3 quarters.
Miller Howard Investments's Medifast position peaked at $345K in Q4 2022.
236 funds tracked by Wall St. Rank held Medifast as of Q2 2023.

Based on Miller Howard Investments's 13F filing for Q2 2023, filed 21 Jul 2023.